P=0.033), SARC (HR=1.355, P=0.014) and THCA (HR=30.871, P=0.049) patients, while CUL7 low expression was associated with poor prognosis in PAAD (HR=0.497, P=0.021) and UVM (HR=0.501, P=0.021). Here, CUL7 is linked to pancreatic adenocarcinoma.